Confronting the founder objection directly
It is a fair objection — and the right place to start. The whole point of giving up IP governance is undone if the founder can use his remaining commercial control to pervert the mission from the other side. This page sets out exactly why he cannot.
The objection, stated plainly
"You've put the patents in a Foundation. Fine. But you still run the OpCo — the entity that holds the exclusive worldwide commercial licence. You set its sub-licensing strategy. You hire its people. You sit at its board table. Even if you've given up governance of the IP, you can pervert the mission from the OpCo side. Why should anyone believe otherwise?"
The architecture was designed on the assumption that the founder, at some future date, would want to pervert the mission — and erects six independent legal gates that would all have to be breached simultaneously, by six different bodies acting in concert, before that perversion could touch the IP, the licensing terms, or the public benefit obligations.
The founder is not trusted to police himself. He is constrained, in writing, by counterparties whose interests are adverse to his own commercial discretion — including counterparties he himself signed contracts with at the moment of maximum founder leverage, before any of those counterparties had any reason to indulge him.
What follows is not an argument that the founder is virtuous. It is an inventory of who else has to agree before the founder can do harm.
Each gate is enforced by a different document, supervised by a different body, and answerable to a different fiduciary duty.
Personal deed — binds the founder, not a company
The founder has executed a personal deed in favour of the Foundation. He cannot dispose of his AUIPCo shares, cannot wind up the IP holder, cannot take any corporate action that would impair the Foundation's rights, and cannot manoeuvre around the Head Licence. The deed binds him personally — not the OpCo, not a board, not a class of shareholders. A succession mechanism activates on death or incapacity.
Bilateral licence — Foundation is the counterparty
The FRAND commitment, the 3% Anti-Accumulation Cap, the Small Entity Exemption, the Transparency Mandate, the Developing Nation Programme allocation, and the Sub-Licensing Review right are expressly irrevocable. The founder, as OpCo CEO, sits on the licensee's side of the table — not the licensor's. He cannot amend them by signing a piece of paper on the OpCo side; the Foundation has to consent. The Foundation has no commercial incentive to consent.
VC Shareholders' Agreement — 75% supermajority gate
Once Series A closes, the founder cannot act unilaterally on the OpCo's most consequential decisions. Amendment of the MLA, change of control, related-party transactions, sub-licensing outside FRAND, and any breach of the Governance Mandate all require 75% shareholder approval — meaning the institutional investors' consent. No competent VC will approve mission-perversion: it destroys the licence they paid to acquire.
Pre-committed founder role transition
The architecture commits the founder, in writing, to transition out of the OpCo CEO role at Series A close and become CTO/Chief Scientist or board director. The Seconded CEO becomes the operational decision-maker on commercial direction, hiring, and sub-licensing strategy. By the time the OpCo is capable of doing meaningful harm at scale, the founder is no longer running it day-to-day. The new CEO answers to the board, the VCs, and the MLA — not to founder loyalty.
Foundation has eyes inside the OpCo
The Foundation appoints a non-voting observer to the OpCo board, with the right to attend every meeting, receive every paper, and monitor every decision. Every proposed sub-licence is independently reviewed by the Foundation before execution. The Foundation's independent directors — Toby Walsh, plus the international AI-safety and civil-society directors — receive real-time visibility into anything the founder attempts. Walsh's job, paid for at $30,000 per year, is precisely to escalate.
Self-executing conversion clause
If the founder somehow caused the OpCo to slow-walk commercialisation — sitting on the licence to suppress the technology rather than deploy it — the licence automatically converts from exclusive to non-exclusive after 24 months. The Foundation can then license a competing operator to actively commercialise. There is no path to permanent suppression. The IP either gets used as intended, or the OpCo loses its monopoly on it.
What the founder would need to defeat
Even granting the objection in full — even assuming the founder, at some future date, becomes a person who actively wants to pervert the mission — the architecture requires the simultaneous, contemporaneous, documented consent of six different bodies whose interests are adverse to his own.
The founder runs the OpCo. He does not own the mission, does not set the licensing terms, does not amend the contract, does not sit on the Foundation board, and cannot stop a competing licensee if he tries to suppress commercialisation. Control of the OpCo is real. It is also tightly bounded.
A note on the timing of these constraints. Each of the six gates is executed before — or contemporaneously with — the moment of maximum founder leverage. The Founder Undertaking Deed is signed at AUIPCo incorporation. The MLA is executed at Foundation incorporation. The Shareholders' Agreement and the founder role transition are signed at Series A close. The Foundation Observer seat is constituted at the same time. The Anti-Exclusive-Lock is in the MLA from day one. There is no future moment at which the founder can be alone with the architecture to weaken it. Each constraint is a pre-commitment with a counterparty already at the table.